Supplements and Featured Publications

Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection
Volume: 21
Issue: 7 Suppl
![Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/05019000301109976bb5bd6b274a4f5482f94f89-900x1229.jpg?w=230&fit=crop&auto=format)
Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]
Volume: 21
Issue: 6 Suppl

Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations [CME
Volume: 21
Issue: 5 Suppl

Economic Evaluation of a Fluocinolone Acetonide Intravitreal Implant for Patients With DME Based on
Volume: 21
Issue: 4 Suppl

Characterizing Pulmonary Hypertension–Related Hospitalization Costs Among Medicare Advantage or Co
Volume: 21
Issue: 3 Suppl

Standards of Care Issues With Anticoagulation in Real-World Populations
Volume: 21
Issue: 2 Suppl
![Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/371bb77085a8399820783447221ceeedad255a69-900x1229.jpg?w=230&fit=crop&auto=format)
Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]
Volume: 21
Issue: 1 Suppl

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Volume: 20
Issue: 14 Suppl

Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Anal
Volume: 20
Issue: 13 Suppl
![Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/69d5242675a80905871256fe7bfe3ffa65a48be6-2363x3226.jpg?w=230&fit=crop&auto=format)
Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes [CME/CPE]
Volume: 20
Issue: 12 Suppl

Implications for Multiple Sclerosis in the Era of the Affordable Care Act: A Clinical and Managed Ca
Volume: 20
Issue: 11 Suppl

Evidence-Based Cardiology - December

Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era
Volume: 20
Issue: 9 Suppl

Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus
Volume: 20
Issue: 10 Suppl

Evidence-Based Cardiology - October

ADA 2014 Conference Coverage

Balancing Therapeutic Safety and Efficacy to Improve Clinical and Economic Outcomes in Schizophrenia
Volume: 20
Issue: 8 Suppl

Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: New Guidelines, Therapies, and
Volume: 20
Issue: 7 Suppl

Clinical Trial Designs in PAH: Shifting From Functional Measurements to Long-term Clinical Outco
Volume: 20
Issue: 6 Suppl

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imagi
Volume: 20
Issue: 5 Suppl

Improving Transitions of Care for Patients With Thromboembolic Disease
Volume: 20
Issue: 4 Suppl

Practical Perspectives on the Management of Overweight and Obesity
Volume: 20
Issue: 3 Suppl

Evolving Strategies for the Management of Multiple Myeloma: A Managed Care Perspective
Volume: 20
Issue: 2 Suppl

Opportunities for Improving Attainment of Quality Measures in Patients With Type 2 Diabetes Mellitus
Volume: 20
Issue: 1 Suppl
Reducing the Impact of Unintended Pregnancies (UIPs) on the US Health System

Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molec
Volume: 19
Issue: 19 Suppl

Castration-Resistant Prostate Cancer: Addressing Treatment Challenges, Managed Care Aspects, and Int
Volume: 19
Issue: 18 Suppl

Special Report: Diabetes Innovation 2013

Current Topics in Multiple Sclerosis
Volume: 19
Issue: 17 Suppl

A Data-Driven Approach to Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CNE/CP
Volume: 19
Issue: 16 Suppl
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
4
How Effective and Safe Are GLP-1s for Weight Loss?
5




